Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.21.1
STOCKHOLDERS' EQUITY (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 19, 2021
Nov. 03, 2020
Aug. 14, 2020
Jun. 03, 2020
Feb. 15, 2021
Jan. 25, 2021
Jan. 25, 2021
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2018
Mar. 28, 2021
Jan. 29, 2021
Nov. 12, 2020
Jan. 31, 2020
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Preferred stock, authorized               5,000,000   10,000,000          
Preferred stock, par value (in Dollars per share)               $ 0.0001   $ 0.0001          
Certificate of designation series A preferred stock     5,000,000                        
Conversion trigger, percentage     25.00%                        
Conversion trigger, per share (in Dollars per share)     $ 6.00                        
Effective interest rate     25.00%                        
Effective conversion price (in Dollars)     $ 6.00                        
Common stock, authorized               116,666,667   116,666,667          
Common stock, par value (in Dollars per share)               $ 0.0001   $ 0.0001          
Common stock, shares issued               26,672,040   26,540,769          
Common stock, shares outstanding               26,672,040   26,540,769          
Aggregate of shares                       8,142,894      
Reverse stock split, description   On November 3, 2020, the Board of Directors of the Company approved a one-for-three reverse stock split of the Company’s authorized and outstanding common stock, effective November 13, 2020 (the “Reverse Stock Split”).                           
shares issued                           116,666,667  
Capital value (in Dollars)                         $ 150,000,000    
Number of warrants to purchase of common stock               131,271              
weighted-average contractual remaining life               2 years 1 month 6 days              
Warrants exercise price (in Dollars per share)               $ 9.75              
Warrants value (in Dollars)               $ 1,279,892              
Stock options to purchase of common stock               593,006   568,006          
Stock options exercise price (in Dollars per share)               $ 7.63   $ 7.39          
Compensation, description           the Compensation Committee approved the following grants: (a) for Messrs. Cohen, Reisfield and Silverman (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (b) for Mr. Seidl and Ms. Sood (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (ii) 10,000 restricted stock units pursuant to the 2018 Plan. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. The 5,000 restricted stock units granted to each of Messrs. Cohen, Reisfield, Silverman and Seidl and Ms. Sood vest in four successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. The 10,000 restricted stock units granted to Mr. Seidl and Ms. Sood vest in eight successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. All restricted stock units granted to these directors shall vest in full immediately upon a change in control. The company recognized stock-based compensation of $111,300 for the three months ended March 31, 2021. As of March 31, 2021, the unrecognized compensation expense was $461,100.                  
Stock compensation expense (in Dollars)               $ 97,162 $ 15,479            
Non vested restricted shares                   6,250,000          
Other Comprehensive Loss, Held-to-maturity Security, Adjustment from AOCI for Accretion of Noncredit Portion of OTTI, after Tax (in Dollars)               $ 3              
2018 Equity Incentive Plan [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Common stock reserved for issuance               3,333,334              
Preferred Stock [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Preferred stock, authorized               10,000,000              
Preferred stock, par value (in Dollars per share)               $ 0.0001              
Warrant [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Number of warrants to purchase of common stock               1,748,532              
Warrants exercise price (in Dollars per share)               $ 9.11              
Warrant [Member] | Minimum [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Warrants exercise price (in Dollars per share)               0.03              
Warrant [Member] | Maximum [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Warrants exercise price (in Dollars per share)               $ 9.75              
Stock Options [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Stock options to purchase of common stock         25,000 90,000 90,000               6,542
Stock-based compensation expense (in Dollars)                   $ 514,866          
Options term         10 years 10 years 10 years                
Stock options exercise price (in Dollars per share)         $ 12.92 $ 12.72 $ 12.72                
Weighted average grant-date fair value (in Dollars per share)         $ 5.82 $ 5.72                  
Stock option values (in Dollars)                             $ 15,479
Number of shares approved by compensation committee             30,000                
Unrecognized compensation expense (in Dollars)               $ 282,000              
Weighted-average contractual remaining life               8 months 12 days              
Thomas Bushey [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Recognized stock based compensation (in Dollars)               $ 1,050,000              
Restricted Stock Units (RSUs) [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
weighted-average contractual remaining life                   1 year 3 months          
Weighted average grant-date fair value (in Dollars per share)               $ 0.64              
Unrecognized compensation expense (in Dollars)                   $ 5,250,000          
Stock compensation expense (in Dollars)                   $ 3,150,000          
Restricted stock purchase       1,000,000             126,160        
Weighted average grant-date fair value of exercise price (in Dollars per share)       $ 8.40                      
Vesting period       2 years       2 years              
Restricted Stock Units (RSUs) [Member] | Thomas Bushey [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Description of restricted stock units Effective January 19, 2021, (i) Mr. Bushey received 500,000 RSU Shares (375,000 RSU Shares vested as of December 31, 2020 and 125,000 RSU Shares on which the Compensation Committee accelerated vesting), which RSU Shares will be issued on June 3, 2022 pursuant to Mr. Bushey’s deferral election, and (ii) 500,000 RSU shares were canceled.                            
Consultant [Member] | Restricted Stock Units (RSUs) [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Stock compensation expense (in Dollars)               $ 0 $ 10,120            
Director [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Stock compensation expense (in Dollars)               270,000              
Recognized stock based compensation (in Dollars)               $ 90,000              
Vesting period               1 year              
Director [Member] | Restricted Stock Units (RSUs) [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Stock Issued During Period, Value, Restricted Stock Award, Forfeitures (in Dollars)           $ 60,000                  
Series A Convertible Preferred Stock [Member]                              
STOCKHOLDERS' EQUITY (Details) [Line Items]                              
Preferred stock, authorized               5,000,000   5,000,000          
Preferred stock, par value (in Dollars per share)               $ 0.0001   $ 0.0001          
Preferred shares designated               5,000,000   5,000,000